Clarius Unveils Updated Ultrasound Software to Enhance Workflows
The latest ultrasound software update from Clarius includes new artificial intelligence (AI) capabilities, coding assistance and a variety of advances tailored to different fields of medicine.
Emphasizing enhancements in workflow efficiency, high-definition imaging, and artificial intelligence (AI) guidance, Clarius has introduced updated software for its handheld ultrasound systems.
One of the features available through the Clarius App 12.0 is a 12-field lung ultrasound scoring tool that facilitates evaluation of patients with respiratory conditions and accurate prognosis of outcomes for those with acute respiratory failure, according to Clarius.
Updated software for Clarius handheld ultrasound devices includes a lung ultrasound scoring tool and coding assistance for ultrasound applications in musculoskeletal imaging, urology and women’s health, according to the company. (Image courtesy of Clarius.)
Clarius noted that other benefits of the updated software include T-Mode real-time AI guidance for assessing grey scale ultrasound images for patients with rotator cuff injuries; a new protocol to facilitate change settings to ensure optimized facial scans for aesthetic procedures; and coding assistance for ultrasound applications in musculoskeletal imaging, urology and women’s health.
“This latest software release, which includes so many unique features, clearly demonstrates the limitless ability of our R&D team to deliver ground-breaking innovations across multiple clinical segments in ultrasound,” noted Ohad Arazi, the CEO of Clarius.
The company said the Clarius App 12.0 was recently launched in Apple and Google Play platforms.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
